Studies on Tumors of the Thyroid

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-98
SponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

About this trial

Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer.

The main purpose of this study is to further understand the methods for the diagnosis and treatment of thyroid nodules and thyroid cancer. Many of the test performed are in the context of standard medical care that is offered to all patients with thyroid nodules or thyroid cancer. Other tests are performed for research purposes. In addition, blood and tissue samples will be taken for research and genetic studies....

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Male or female, adults or children >= 6 months+.

Patients with known or suspected thyroid nodules and/or thyroid cancer.

At risk family members of patients who have a genetic susceptibility to developing thyroid cancer.

Disqualifiers

None

Trial population

Only those with thyroid nodules and/or thyroid cancer will be allowed to enroll.

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

  • 68-Gallium Dotatate

    Drug

    For evaluation risk/benefit evaluation

Treatment groups

2,500 Participants
are divided into 2 treatment groups
Group A: thyroid cancer1 intervention
Group B: thyroid nodules1 intervention

Trial outcomes

Primary outcomes

1

Evaluation of thyroid cancer

Blood draws, CT and other scans, physical exams, surgery (if applicable), thyroid biopsy (if applicable).

Time frame
As clinically indicated
2

Evaluation of thyroid disorders

blood draws, CT and other scans, physical exam.

Time frame
As clinically indicated

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.